GlassScriptPhysician profile
Mariana Ellington
NPI 1447712005
$904.61
in general payments reported to CMS, 2019-2025
19 companies · $444 in 2025
The $444 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $22.47 · 2023: $151 · 2024: $287 · 2025: $444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $882.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $882.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $113.16 | 2024-2025 | |
| Exeltis, USA INC. | $90.96 | 2023-2025 | Slynd |
| Mayne Pharma Commercial LLC | $88.87 | 2023-2025 | |
| Abbvie INC. | $86.41 | 2023-2025 | |
| Biogen, INC. | $82.02 | 2025 | Zurzuvae |
| Organon LLC | $75.17 | 2024-2025 | Nexplanon, Jada System |
| Lilly USA, LLC | $46.04 | 2025 | Zepbound |
| Hologic Sales and Service, LLC | $43.63 | 2023-2024 | Thinprep 2000 Processor, Aptima, Fetal Fibronectin Enzyme Immunoassay |
| Pfizer INC. | $38.72 | 2023-2024 | |
| Astellas Pharma US INC | $38.63 | 2023-2024 | Veozah |
| Davol INC. | $31.83 | 2023 | Arista Ah Flexitip |
| Bayer Healthcare Pharmaceuticals INC. | $30.30 | 2024 | |
| Evofem Biosciences, INC. | $23.39 | 2025 | Phexxi, Solosec, Phexx |
| Merck Sharp & Dohme LLC | $22.85 | 2024 | Gardasil, Gardasil 9 |
| Boston Scientific Corporation | $22.47 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $19.68 | 2025 | Wegovy |
| Sanofi Pasteur INC. | $19.50 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.32 | 2025 | Trintellix |
| Minerva Surgical, INC | $13.66 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mariana Ellington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.